There is no doubt that cancer is a devastating disease. However, restraining the cancerous cells from spreading throughout the body (invasion) will make it easier to control and possibly cure cancer. β-catenin is one of the proteins inside the cells of our body which when translocating into the nucleus, it presses the buttons required for cell invasion into the surrounding area through modulating the expression of certain genes that are responsible for the process of cell migration, invasion, and metastasis.

Fig. 1. Low FLYWCH1-mRNA expression significantly associates with advanced tumours. A) The mRNA expression of several tumorigenic and proinavsive β-catenin/TCF4 target genes in cells expressing either GFP-FLYWCH1 (blue) or GFP-FLYWCH1-shRNA (red) relative to the control cells expressing GFP (White). B) Correlation of the mRNA expression of FLYWCH1 to EPHA4 and ZEB1 in a cohort of thirty-three; normal, primary, and metastatic tumour tissues. C) photomicrographs of colorectal cancer-TMA specimens analyzed by ISH using a specific FLYWCH1 probe with strong (left), moderate (middle), and weak (right) expression. The lower panel shows a correlation between FLYWCH1 expression and tumour staging. Weak expression of FLYWCH1 is associated with the more advanced stage of a tumour. N/A: samples were not available on slides after staining and perhaps wiped off through the ISH process.

Here, we introduce a guardian molecule called FLYWCH1, who interacts with and opposes the oncogenic activity of nuclear β-catenin by selectively suppressing its transcriptional activity. For example; FLYWCH1 decreases the level of Wnt target genes associated with cell morphology and migration, such as ZEB1 and EPHA4, while increases genes that promote cell attachment such as E-cadherin. Importantly, this effect was reversed by knocking down FLYWCH1 expression using siRNA technology (Fig. 1A).

Also, there is a significant correlation between low level of FLYWCH1 and increased of ZEB1 and EPHA4 in normal versus advanced-stage tumours (Fig. 1B). Interestingly, a negative correlation between FLYWCH1 expression and tumour progression (70.8% vs. 25.7%, P ≤ 0.017; Fig. 1) in a series of early and advanced/metastatic patient’s colorectal cancer tumours was also observed (Figure 1C). These findings support the notion that FLYWCH1 may selectively modulate the transcriptional activity of Wnt/β-catenin signalling pathway, and its expression is necessary to prevent tumour metastasis.

Based on our findings we propose that in the absence of FLYWCH1, β-catenin binds to its long-term partner protein TCF4 and activate the genes that are required for tumour invasion through reducing cell attachment and enhancing cell migration (Fig. 2B). However, in the presence of FLYWCH1, β-catenin can no longer bind to TCF4 and fails to activate the genes that are required for cell motility and attachment resulting in impaired invasion and metastasis (Fig. 2A).

Fig. 2. Schematic representation of the regulatory role of FLYWCH1. A) In the presence of FLYWCH1, β-catenin can no longer bind to TCF4 and fails to activate the genes that are required for cell motility and attachment resulting in the impaired invasion. B) In the absence of FLYWCH1, β-catenin binds to TCF4 and activates genes that are required for tumour invasion through reducing cell attachment and enhancing cell migration.

This study, for the first time, characterizes and describes a possible anti-metastasis and tumour suppressive role of FLYWCH1 in the context of the Wnt/β-catenin signalling pathway. We believe that FLYWCH1 has the potential to be considered as a biomarker and therapeutic target against metastatic colorectal cancer in the future.

Belal A. Muhammad, Sheema Almozyan, Abdolrahman S. Nateri
Cancer Genetics and Stem Cell Group, Division of Cancer and Stem Cells, University of Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, United Kingdom

Publications

FLYWCH1, a Novel Suppressor of Nuclear β-Catenin, Regulates Migration and Morphology in Colorectal Cancer.
Muhammad BA, Almozyan S, Babaei-Jadidi R, Onyido EK, Saadeddin A, Kashfi SH, Spencer-Dene B, Ilyas M, Lourdusamy A, Behrens A, Nateri AS
Mol Cancer Res. 2018 Dec

Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells.
Almars A, Chondrou PS, Onyido EK, Almozyan S, Seedhouse C, Babaei-Jadidi R, Nateri AS
Int J Mol Sci. 2019 Jun 4

Read offline:     

Related Articles:

	Gastrointestinal stromal tumor transition to… Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. GISTs generally contain oncogenic gain-of-function KIT (~85%) or PDGFRA (~5-10%) mutations which are crucial for GIST…
	BioID screen for bacterial virulence proteins: new… The discovery of penicillin in the 1920s revolutionized our ability to treat bacterial infection. However despite the introduction of antibiotics, infectious bacterial pathogens remain an immense challenge for the healthcare…
	Tracking mRNA in living cells using Pepper RNA aptamer Messenger RNAs (mRNAs) are a class of biomolecules that are generated in the nucleus to carry genetic information from the nucleus to different parts of the cells for making functional…
	The complementary anti-inflammatory and anticancer… Inflammation is an important and extremely complex biological process involving a high number of mediators responsible for the activation of multiple cascades, providing a wide range of possible targets for…
	Purification and characterization of a… Alzheimer’s Disease (AD) is an incurable disease that causes memory, reasoning and thinking to deteriorate over time. AD is marked by brain atrophy and plaque-like deposits of a small peptide…
	Novel genetics approach identifies GNAS gene as an… Type 2 diabetes mellitus (T2D) is a major health burden in developing and industrialized countries (www.idf.org). Common genetic variations, susceptibility genes, epigenetic regulation, and miRNAs have been suggested to be…